Literature DB >> 20087324

Validating studies of adherence through the use of control outcomes and exposures.

M Alan Brookhart1, Amanda R Patrick, William H Shrank, Colin R Dormuth.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20087324     DOI: 10.1038/ajh.2009.232

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  6 in total

1.  Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations.

Authors:  Milica Nikitovic; Daniel H Solomon; Suzanne M Cadarette
Journal:  Ther Adv Chronic Dis       Date:  2010-11-01       Impact factor: 5.091

2.  Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.

Authors:  Leah J McGrath; Alan R Ellis; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-04-12       Impact factor: 4.897

3.  Control Outcomes and Exposures for Improving Internal Validity of Nonrandomized Studies.

Authors:  Stacie B Dusetzina; M Alan Brookhart; Matthew L Maciejewski
Journal:  Health Serv Res       Date:  2015-01-19       Impact factor: 3.402

4.  Effect of statin use on acute kidney injury risk following coronary artery bypass grafting.

Authors:  J Bradley Layton; Abhijit V Kshirsagar; Ross J Simpson; Virginia Pate; Michele Jonsson Funk; Til Stürmer; M Alan Brookhart
Journal:  Am J Cardiol       Date:  2012-12-28       Impact factor: 2.778

5.  Negative control exposure studies in the presence of measurement error: implications for attempted effect estimate calibration.

Authors:  Eleanor Sanderson; Corrie Macdonald-Wallis; George Davey Smith
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

6.  Association between gaps in antihypertensive medication adherence and injurious falls in older community-dwelling adults: a prospective cohort study.

Authors:  Paul Dillon; Susan M Smith; Paul John Gallagher; Gráinne Cousins
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.